Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization. [electronic resource]
Producer: 20130515Description: 994-1004 p. digitalISSN:- 1476-5586
- Animals
- Cell Transformation, Neoplastic -- genetics
- Complement Activation -- immunology
- Complement C3 -- deficiency
- Complement C5a -- antagonists & inhibitors
- Complement System Proteins -- drug effects
- Endothelial Cells -- drug effects
- Female
- Humans
- Lymphocytes, Tumor-Infiltrating -- immunology
- Male
- Mice
- Mice, Transgenic
- Neovascularization, Pathologic -- immunology
- Ovarian Neoplasms -- blood supply
- Peptides, Cyclic -- pharmacology
- Protein Isoforms
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.